InvestorsHub Logo

EM

Followers 7
Posts 879
Boards Moderated 0
Alias Born 09/21/2016

EM

Re: None

Saturday, 01/14/2017 8:31:36 AM

Saturday, January 14, 2017 8:31:36 AM

Post# of 8449
Found this
http://pitchbook.com/profiles/novotyr-therapeutics-profile-investors-funding-valuation-and-analysis

Details
http://www.firstwordpharma.com/node/29233?tsid=17#axzz4VjzLPNqB

- Teva invested $1 million in Novotyr Therapeutics and has an option to invest several million dollars more for a 27 percent stake in the company, Globes online reported today.

- Novotyr is developing inhibitors of an insulin-like growth factor receptor as drugs for the treatment of cancer and other diseases. The company plans to begin clinical trials in 2009.

Novotyr was the previously name of Tyrnovo.

Still have to do some DD about, but looks like there is Teva behind Novotyr and his illuminated co-founder Alexander Levitzki (where he served ad Member of Scientific Advisory Board).
http://www.bloomberg.com/research/stocks/people/person.asp?personId=6313122&capId=6313094&previousCapId=6700309&previousTitle=United%20States%20Department%20Of%20Agriculture

Waiting for PR where Management can explain this new strategy.